Cite
MLA Citation
Daniela Bianconi et al.. “Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC.” Therapeutic advances in medical oncology, vol. 12, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100105247300.0x0000f0